Gut mucosal mast cells. Origin, traffic, and differentiation by unknown
GUT  MUCOSAL  MAST  CELLS 
Origin, Traffic, and Differentiation 
BY  DELPHINE GUY-GRAND,*  MICHEL DY,* GI~RARD LUFFAU,  ~ ANn 
PIERRE  VASSALLI  I 
From the *Groupe d'Immunologie et de Rhumatologie pidiatrique  (1NSERM U 132), the *Unit~ 
INSERM U 25, H~pital Necker-Enfants malades, 75730 Paris Cidex 15; the OINRA, 78850 
Thiverval Grignon, France; and from the I  Department of Pathology, University of Geneva, 
1211 Geneva 4, Switzerland 
Mast cells are observed in the gut mucosa of normal rats,  primarily in  the 
lamina propria (LP)  1 and to a lesser extent in the epithelium. Their number and 
presence in the epithelium strikingly increase in nematode-parasitized rats, e.g. 
after infestation by Nippostrongylus brasiliensis (Nb) (1). In normal mice, mucosal 
mast cells (MMC) are nearly absent from the gut and appear in nematode-infested 
mice, almost exclusively in an intraepithelial location (2). 
MMC differ from serosal mast cells (SMC) (see reviews, references 3 and 4) in 
that they contain smaller and less numerous granules and nonidentical amines 
and in requiring special fixatives for their certain identification in tissue sections 
(see  Materials  and  Methods).  MMC  also  differ  from  SMC  by  their  T  cell 
dependence for in vitro proliferation and differentiation. 
In vitro, mouse mast cell lines with the biochemical and cytological properties 
of MMC and basophils (5),  have been obtained mostly from bone marrow cell 
(BM) cultures. The factor responsible for MMC proliferation and differentiation 
in these conditions is present in the supernatant of Con A (6-8) or antigen (Nb) 
(9) stimulated T  cells, and is also present spontaneously in large amounts in the 
supernatant of the mouse Wehi 3 tumor (W3 sup)(10,  1 1). This factor, named 
IL-3, has been extensively purified and shown to be  identical to the mast cell 
growth factor (MCGF) and to the "histamine-producing cell stimulating factor" 
(HCSF) (12).  IL-3 also has a  colony-stimulating factor (CSF)  activity, and may 
correspond to a  "multispecific CSF" (13).  In this paper,  the name IL-3 will be 
used to describe the factor(s) present in W3  sup that acts on MMC and their 
precursors (MMC-P), and induces the continuous growth of MMC culture (MCGF 
activity) and the release of histamine by BM cells (HCSF activity). 
In vivo, the T  cell dependence of MMC is well established. Nude mice, which 
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have  normal  SMC,  do  not  develop  gut  MMC  when  they  are  infested  with 
nematodes (2). In Nb-infested rats, the increase in gut MMC is correlated with 
the presence of specific immune T  lymphocytes circulating in the thoracic duct 
lymph (TDL) (14,  15). 
In  the present  work,  we  studied  the  properties,  frequency, cell traffic, and 
conditions of differentiation of MMC-P into gut, MMC,  in normal mice as well 
as in mice bearing a  Wehi  3  tumor, and in mice and rats infested with Nb.  In 
this latter situation, the appearance of gut MMC in large numbers results from 
a  combination of the peculiar traffic properties of the gut T  lymphocytes (16) 
and  of their ability to release,  upon  contact with  Nb  antigen,  unusually  large 
amounts of IL-3. 
Materials and  Methods 
Animals and In  Vivo Treatments.  C57B1/6,  BALB/c,  Nude  (Swiss), germ-free mice 
(Swiss) were obtained from Iffa Credo or CNRS Orl6ans, France. Lewis rats were raised 
in our animal house. Animals bearing graft of fetal intestine were grafted subcutaneously 
with  18-d old fetus gut at least 20 d  before utilization (16). Some BALB/c mice were 
injected subcutaneously or intraperitoneally with  5  ×  106  Wehi  3  B  tumor cells  and 
sacrificed  15  d  later.  For immunization  by Nb,  infective larvae (L3) were inoculated 
subcutaneously into the flank region of adult female animals (700 L3 in C57B1/6 mice, 
3000L3 in Lewis rats). Selective irradiation of mesenteric lymph nodes (MLN) or spleen 
were performed with pieces of mp containing polyvinyl chloride (CEA, Saclay, France) 
(16).  For selective depletion of dividing cells, mice received intraperitoneally, four times 
over 20 h, 0.06 mg of vinblastine sulfate and were sacrificed 3 h after the last injection. 
Thoracic duct cannulation was performed in rats according to Ford and Hunt (17) and 
in mice as previously described (I 8). Colony-forming unit-spleen assay was performed by 
injecting various number of cells (105 to 7.5 x  105) from BM, spleen, and gut mucosa into 
lethally irradiated syngeneic mice. Colonies were scored macroscopically  and histologically 
at day 7. 
Preparation of Cell Suspensions.  Cell suspensions from lymphoid organs were prepared 
by pressing small fragments through a wire mesh no. 100. BM was obtained by flushing 
the femurs. Intraepithelial lymphocytes (IEL) were obtained as previously described in 
normal mice (16): after washing the gut and removing the Peyer's patches (PP), the small 
bowel  was  opened and  flattened. The epithelium  was  scraped with a  scalpel and the 
fragments obtained were dissociated with a magnetic stirrer for 5 rain in medium  199 
(Gibco Europe-Uxbridge UB8 2YG Middlesex, England) with 20% fetal calf serum (FCS) 
and 1 mM dithiorerythritol for 10 rain. The washed suspension was then shaken vigorously 
on a Vortex mixed for 3 min, and filtered quickly through a buffered glass wool column 
(1.8 g  packed in a  20-ml  syringe). Dead cells and debris were eliminated on a  Ficoll 
Isopaque gradient (19). This procedure yields 2-8 x  106 nonepithelial cells per mouse in 
a rather pure form. In rats the procedure was similar, but better results were obtained 
with a smaller glass wool column (0.5 g) and the use of Percoil gradient (20). The average 
yield varied between 15 and 30 ×  10°nonepithelial cells per rat. In Nb-infested animals, 
particularly during the self-cure, the isolation was ~more difficult because lymphoid cells 
stuck to the glass wool and therefore smaller columns were used; however the cell recovery 
was lower and epithelial cell contamination was unavoidable. In all cases,  no cells from 
the LP were isolated with IEL, since no plasma cells were observed among the isolated 
cells. Isolation of LP cells was performed in mice by a modification of the procedure of 
Davies and Parrot (20): the washed small bowel, after removal of PP, was cut in 1-cm long 
fragments, which were submitted to magnetic stirring in RPMI (Gibco Europe) plus 10% 
FCS  (three  times,  15  min  each).  This  treatment  removes the  villous epithelium  but 
preserves the crypt epithelium, as seen on histological sections. Use of EDTA was avoided 
in infested mice because it leads to a  low yield of LP cells.  The fragments were then 
transferred to flasks containing 15 mi RPMI  with 20%  FCS and 45 #g/ml collagenase 14  GUT  MUCOSAL  MAST  CELLS 
(Sigma Chemical Co., St.  Louis, MO) at 37°C and incubated with magnetic stirring for 
60 min. Disruption was achieved by pumping through a 10-ml syringe. The cell suspension 
was filtered through a wire mesh, washed, and passed through a glass wool column (0.4 
g) and a  Ficoll Isopaque gradient as for IEL. The procedure yields ~.2  x  106 cells per 
animal. These cells are not pure LP cells since they include crypt cells,  but are mucosal 
cells devoid of villous epithelium IE cells. They will be referred to as "gut mucosal cells." 
Separation  of Cell Subsets.  Cytotoxicity or panning procedures (or combination of the 
two techniques)  were used.  In mice, elimination of Thy-1 ÷ or Lyt-2  + lymphocytes was 
performed by incubating cells with  monoclonal rat anti-Thy-1  (AT  83) or anti-Lyt-2 
(14.281) (kind gift of F. Fitch, University of Chicago). Low-tox-M rabbit complement (CL 
3051, Cedarlane, Hornby, Canada) was then added (final dilution 1/10). For cell separation 
by panning (21) the same antibodies were used to coat the cells which, after washing, were 
incubated in dishes coated with goat anti-mouse Ig. In rats, the monoclonai antibody used 
was MRC Ox 8 (Sera-Lab, Grawley Down, Sussex, England). The purity of the separated 
cells was verified after each separation by immunofluorescence, Velocity sedimentation at 
1 g in FCS gradient was performed as described (22). 
Immunofluorescence, Histological, and Cytological Procedures, Labeling, and Radioautogra- 
phy.  In mice, cells were stained separately or in combination with a rhodamine-labeled 
rabbit anti-Thy-1 antibody (23), with monoclonal rat anti-Lyt-2 (14.281) and Lyt-1 (AT 
105) followed by a fluorescein-labeled mouse anti-rat Ig, with a rhodamine- or fluorescein- 
labeled goat anti-mouse Ig (Nordic Tilburg, The Netherlands),  and with a  rhodamine- 
labeled  anti-mouse  #,  3',  or  a  chain  rabbit  antiserum,  as  previously  described  (24). 
Monoclonal mouse IgE was a generous gift of Dr. I. B6ttcher (IgE 14205) (25) and was 
applied a l/s0 dilution for 3 h for detection of IgE receptors on cultured cells (see below). 
Controls were incubated with I/5 diluted normal mouse serum. In the absence of a labeled 
anti-mouse e chain,  IgE was  detected,  on  cultured  cells  or  on  isolated  MMC,  by the 
positivity of the  fluorescence with goat anti-mouse Ig compared to the negativity with 
anti-v, -3", and -a rabbit antisera. In the last experiments of this series, a rabbit anti-mouse 
e-chain, obtained by immunization with monoclonal IgE (IgEL b4, American type culture 
collection TIB  141),  and  made specific by appropriate absorptions,  was available and 
found to give comparable results. In rats, the rabbit anti-mouse a-chains antiserum was 
used to detect IgA plasma cells. An anti-IgE was prepared by immunization of a rabbit by 
rat myeloma IgE IR 162 (generous gift of D'r. H. Bazin, University of Louvain) followed 
by appropriate absorptions. All these antisera were used either on isolated viable cells or, 
when possible, on tissue sections (frozen or after Carnoy fixation). 
Labeling of dividing cells was obtained in vitro as described (16), or in vivo by a single 
injection of 1 #Ci SH-TdR (CEA Saclay, France) per gram of body weight. 
For histological studies, tissues were fixed in Carnoy's fluid.  For detection of mouse 
MMC, tissues were fixed in the fluid described by Ruitenberg and Elgersma (2) which, in 
our hands, was the most appropriate for good visualization of MMC with toluidine blue 
(Fig.  1).  In rats, tissues were fixed in Carnoy's fluid as described by Enerb/ick (26) and 
MMC  were  stained  by Alcian  blue,  pH  0.3  and  Safranin  (27).  For autoradiography, 
sections were stained by Alcian blue, then by anti-a chains antiserum before dipping in 
photographic emulsion (Iiford K5). Slides without staining of plasma cells were counter- 
stained by Safranin after developing (Fig. 3). 
Cytocentrifuged smears were stained as described (16). For detection of MMC raised 
in cultures, unfixed smears were immediately stained by May Grumwald Giemsa (the use 
of prior alcohol fixation was found to decrease the number of MMC granules). For studies 
of cells labeled with fluorescent antibodies, the smears were mounted in tetrahydrofurfuryl 
alcohol (which preserves granules). For subsequent Giemsa staining of cells labeled with 
fluorescent antibodies, the exact position of groups of fluorescent cells on the slide was 
determined with Vernier markings, and the  respective position of the fluorescent and 
nonfluorescent (i.e., detected by phase contrast only) cells recorded by picture or hand 
drawing. The slide was then stained with May Grumwald Giemsa, and the same groups 
of cells identified, thus allowing to determine the cytologic characteristic of the fluorescent 
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FIGURE  1.  Gut  tissue  section  of a  mouse  bearing  a  Wehi  tumor,  toluidine  blue  stain. 
Numerous  MMC containing  red metachromatic  granules are located in the crypts and the 
bottom of the epithelium villous. 
Celt Cultures and Studies of Supernatant Activities.  Cell  cultures  were performed in 
Dulbecco's supplemented medium (Gibco Europe) with 10% FCS. Limiting dilution assays 
for detection of MMC-P were carried out by culturing eight appropriate concentrations 
of tested cell populations in 96 flat-bottom wells (Falcon 3040 Becton Dickinson, Oxnard, 
CA),  12 wells  per cell concentration.  Each  200-tA  well contained,  in addition,  1 ×  106 
irradiated  (4,000  rad)  syngeneic spleen  cells and  an  optimal concentration  of W3  sup 
(-5%). After 7-12 d, cells from growing colonies were studied on May Grumwald Giemsa- 
stained smears. The frequency of MMC-P was determined by using Poisson probability 
distribution (28). 
For  the  detection  of interleukin  release,  cultures  of various  lymphoid organs  were 
performed, using 1 ×  106 or 10 ×  106 celis/ml in the presence of Nb antigen or antigen 
extracted from L3 larvae, 50 equivalent worms/ml (as described) (29) or of Con A, 5 ug/ 
ml (I.B.F. Viileneuve La Garenne, France) (see text and Tables II and III). 
IL-3 was assayed as  MCGF  (21)  and  HCSF (30),  and  IL-2 was assayed on  a  IL-2- 
dependent cell line as described (21). In addition, IL-3 was also tested by the induction of 
MMC in cultures of normal mouse gut mucosal cells.  104 cells were plated as for limiting 
dilution cultures with various dilutions of the supernatant to be tested, and MMC growth 
detected as described above. Results of IL-3 assays or of W3 sup activity were compared, 
in some cases, with those obtained with highly purified IL-3 (gift of Dr.  Ihle, National 
Cancer Institute, NIH) (12). 
Results 
A. Gut mucosal Mast Cells (MMC) and Their Precursors (MMC-P) in 
Noninfested Mice 
In the gut of normal  mice,  MMC are extremely rare and almost exclusively 
intraepithelial,  located within the crypts and at the base of the villi (never more 
than 5 MMC per 10 crypt villi).  MMC-P are defined as those cells that grow and 
differentiate,  when cultured  in  IL-3-rich medium,  into cell populations  rich in 
or composed exclusively of MMC. 
1.  Localization  and  Frequency  of MMC-P.  (a)  In  Vitro  studies,  using  IL-3- 
stimulated cultures with limiting dilutions of cells obtained from various locations. 
As a source of IL-3, culture W3 sup were used; in several experiments, identical 
results were obtained using highly purified IL-3 from W3 sup (12). 
As shown  in  Table  I,  MMC-P are found  in  various  lymphoid organs,  in  the 
BM  and  among  circulating  cells  as  well  as  among  gut  mucosa  lymphoid  cells 16  GUT  MUCOSAL  MAST  CELLS 
FIGURE 2.  Smears of gut intraepithelial cells from Nb-infestecl mice. May Grumwald Giemsa 
performed on cells showing membrane IgE by immunofluorescence (early MMC, and granu- 
lated lymphocytes, devoid of lgE Fc receptors, and thus unstained by immunofluorescence. 1 
and 2: early MMC (day 8, beginning of the self cure, showing lgE fluorescence, and nonflu- 
orescent granulated lymphocytes. 3, 4, 5: Various aspects of MMC observed on day 13; the 
cells have variable number of grains, but all bear membrane IgE detected by immunofluores- 
cence. Aspects of MMC differentiation in vitro were indistinguishable. GUY-GRAND ET AL. 
TABLE I 
MMC-P Frequency* in Various Organs of  Mire 
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Gut mu-  BM  Spleen  c°sa I  PP  MLN  TDL  PLN 
Normal C57BI/6 mice  900  34  700  25*  6  3  <1.5 
Nb-infested C57B!/6 mice 
day 9-10  900  350  10,500  65  *!  120  !  330!  <1.5 
day 15  80  1,500  20  12 
Nude mice  450  50  1,700 
Germ-free mice  800  140  2,000 
Normal BALB/c  800  70  3,000  6  <1.5 
BALB/c with: 
Wehi i-p  5,000  1,250  5,000  <1.5 
Wehi sub-cut  36 
* Average of 2-6 experiments. Number of precursors for l0  s cells. 
* Always contaminated by MMC-P present in the adjacent epithelium. 
i On day 9, the total cell number obtained from MLN and from 25 h TD drainage showed a twofold 
increase, while PP showed a twofold cell decrease. 
I Gut mucosal cells comprise LP cells and IE cells from the crypts. Pure IE cells coming from the 
villous epithelium (see Materials and  Methods) contain ~100  MMC-P per  106 cells; the MMC-P 
frequency in villous epithelium IE cells cannot be tested in  Nb-infected mice, because in these 
conditions IE cell recovery from the villi is made difficult and poorly reproducible because of the 
thick layer of mucus covering the gut. 
(comprising LP cells and IE cells from the crypts, see Materials and Methods). 
However, limiting dilution analysis shows that their frequency varies enormously 
among cells from these different origins:  they are most  frequent among gut 
mucosa and BM cells, extremely rare in  lymph nodes (LN) and among TDL, 
and somewhat more common among spleen cells. The results obtained with PP 
cells may be distorted by contamination by gut mucosal cells (see below). The 
strikingly high frequency of MMC-P among gut mucosal cells must result from 
homing to  the  gut  wall  of precursors  from  the  BM,  since  undifferentiated 
hematopoietic stem cells are absent from the gut mucosa, as found by CFU assay 
(not shown, see Materials and Methods). This impressive gut-homing of MMC- 
P,  which contrasts with  the very small dissemination of these cells cannot be 
attributed to lymphokine release from antigenically stimulated gut T  lympho- 
cytes, since it  is observed in  athymic nude mice as well as in  germ-free mice 
(Table I), and in sterile gut fetal graft (where it appeared to be similar to that of 
host  gut,  although  the  small  number  of cells  recovered precluded a  precise 
limiting dilution analysis). Furthermore, although their frequency is more diffi- 
cult to  evaluate in  the gut of very young mice, because of the possibility of 
contamination by residual PP, gut MMC-P are easily detectable in 2-, 5-, and 15- 
d  old mice, i.e., at the time when there are no IgA and T  cells in the LP, as 
judged by immunofluorescence. In adult mice, gut  MMC-P appear  to have a 
definite, although  very small,  tendency to  pass  into  the gut  draining  lymph, 
judging from the MMC-P frequency in MLN, which is at least four times higher 
than in popliteal lymph nodes (PLN), and the presence of very few MMC-P in 
the TD lymph. 
(b)  In  vivo  studies  of MMC appearance  in  BALB/C  mice bearing grafted  Wehi  3 
tumor cells. 18  GUT  MUCOSAL  MAST  CELLS 
In these mice, which received Wehi 3 cells subcutaneously or intraperitoneally, 
and whose blood contained detectable levels of IL-3, mature MMC were found 
in the BM and in the splenic red pulp (which was also strikingly hematopoietic) 
and, conspicuously, in the gut mucosa. In this last location, they were intraepi- 
thelial, mostly within the crypts and the bottom of the villi (85 per 10 crypt villi) 
(Fig.  1), and also in the epithelium covering the thymic-dependent area of the 
PP. No MMC were observed in the LN, nor in any of the mucosae examined, 
i.e.,  tracheal, bronchial,  esophageal,  uterine, urinary, and skin.  However, the 
number of serosal  MC  observed  in  the dermis was  markedly increased.  The 
frequency of MMC-P (certainly including in  this situation young proliferating 
MMC) determined in vitro from the BM, spleen, MLN, and gut LP cells was 6- 
to 20-fold increased compared to normal mice, while it was unchanged among 
PLN (Table I). 
2. MMC-P Traffic.  MMC-P appear to home directly from the blood to the 
gut mucosa, rather than passing via TD lymph, like gut T  cells (16) since MMC- 
P frequency is extremely low in normal TD lymph. To explore more directly 
MMC-P traffic and compare it to that of gut T  cells in normal and Nb-infested 
mice (see below), TD was cannulated for 2 d. This resulted in a slight increase 
rather than decrease in gut MMC-P frequency, emphasizing the very low circu- 
lation of these cells through lymph. To explore whether blood-borne MMC-P 
come directly from the BM or pass through the spleen (since this organ contains 
5-20 times more MMC-P than other lymphoid organs), gut MMC-P frequency 
was determined in mice whose spleens had been selectively irradiated for 5  d 
with a  32p  strip,  or surgically removed, and was not found to be significantly 
modified. 
3.  Characteristics  of  the  Gut  MMC-P  and  of  Incompletely  Differentiated 
MMC.  MMC-P  do  not  bear  Thy-1  or  Lyt-2  antigens,  since  prior  cytotoxic 
treatment of gut  mucosal  lymphoid cells  with  the appropriate  antibodies  in- 
creased their frequency, as detected by limiting dilution analysis (not shown). 
This was confirmed with IEL, which contains numerous Lyt-2  + cells with granules 
resembling those of mast cells, and whose isolation includes some MMC-P: Lyt- 
2 + cell depletion increased MMC-P frequency about 6 times (from 1/21,000  to 
1/3,400,  average values).  Gut  MMC-P are not rapidly replicating, since their 
frequency is  not  significantly modified after  24  h  of in  vivo  treatment with 
vinblastine (not shown), which lead to gut epithelial crypt necrosis. 
Gut MMC-P appear to differ somewhat from BM MMC-P, since: (a) BM mast 
cell clones proliferate faster, frequently contain Iobulated nuclei suggestive of 
basophils, and, when undifferentiated, are weakly stained with anti-Thy-1  but 
not  anti-Lyt-1  or  -2  antibody,  suggesting  the  transient  acquisition  of Thy-1 
before full differentiation, in  agreement with observations of Schrader et al. 
(31); (b) BM MMC-P are known to be large dividing cells (32), and their absolute 
number decreases after in vivo vinblastine treatment (not shown); (c) BM cells, 
within 48 h of exposure to I L-3, synthesize and release large amounts of histamine 
in the culture medium (33), while no histamine is released by gut mucosal cells 
in  the  same  conditions  (data  not  shown).  Thus,  it  is  likely that  gut  MMC-P 
represent a more differentiated precursor than BM MMC-P. 
In cultures in  which MMC are going to  emerge, whatever the source used GUY-GRAND ET AL.  19 
(gut, TDL, spleen), their immediate precursors appear to be large blasts, with 
focal small granules within vacuoles; not all these blasts bear IgE receptors (see 
Materials and Methods). This indicates that the acquisition of IgE receptors is 
the earliest event clearly indicating mast cell differentiation, in agreement with 
other observations (34). 
B.  Gut MMC, Their Precursors, and Their Inducers in Nb-infested Mice 
NB expulsion from the gut ("self-cure") takes place, in the mouse, between the 
8th and the 12th d after infestation. 
1. Nature of the Dividing  Cells in the Gut Mucosa.  Starting around day 8 the 
gut mucosa contains a high number of dividing "lymphoid" cells whose increase 
and nature can be best studied after gut mucosal cell isolation from the epithe- 
lium. Up to  12%  of the isolated cells are labeled after  1 h  of culture with SH- 
TdR (0.5% in normal mice). These labeled cells contain the following cell types: 
(a) immature MMC (~16%), which are large Thy-l-, Lyt-l-, -2- blasts, bearing 
IgE receptors (see Materials and Methods), with small granules containing some 
histamine (detectable by the OPT reaction) (16), thus identical to the early MMC 
appearing in culture as described above (Fig. 2); (b) Thy-1- Lyt-2  ÷ blasts, usually 
containing rather large alcianophilic granules and never bearing IgE receptors 
(32%); (c) Thy-1 ÷ blasts of the Lyt-2- (9%) and/or Lyt-2 ÷ (43%) phenotype; (d) 
a  few Thy-l-,  Lyt-2-, and sIg- blasts.  More mature MMC, with large granules 
and a smaller size, can be isolated or identified on tissue sections around day 10; 
they are mostly located within the epithelium of the crypts and become especially 
conspicuous on day  13 (Table IV), at which time they contain more histamine 
and are no longer dividing. Their number decreases very rapidly in the following 
days (Table IV). 
2. Localization and Frequency of  MMC-P and Proliferating MMC.  As mentioned 
above for Wehi  3  tumor-bearing mice, limiting dilution analysis of MMC-P in 
Nb-infested mice also detects proliferating MMC, especially in the gut mucosa; 
for simplicity, all these cells will be called MMC-P.  Table I  shows the MMC-P 
frequency in various  organs  between  day  9  and  10  of infestation.  There  is a 
more than  10-fold increase in the gut mucosa, as expected, and most of these 
cells are dividing, as shown by the observation that 24 h in vivo treatment with 
vinblastine (day 8) leads to a two- to sevenfold decrease in the absolute number 
of MMC-P.  In three other locations, MMC-P frequency is markedly increased: 
spleen, MLN, and TDL. The cell recovery of MLN and TDL is about twice, and 
the percentage of 3H-TdR-labeled cells three times above normal (respectively 
6% and  1.8%).  Some TDL blasts are Thy-l-,  sIg-, but no granules were ever 
seen. Since the massive increase of circulating MMC-P found in the TDL could 
explain the increased MMC-P frequency observed in the spleen, this possibility 
was explored by cannulating the thoracic duct between the 8th and  10th day 
and then assessing the spleen MMC-P frequency. Since this figure was unchanged 
(not shown), it appears that the spleen MMC-P increase does not result from the 
accumulation of cells released  in  the blood from the  thoracic  d~ct  (and  thus 
originating in the gut wall and MLN), but from a  source of IL-3 present in the 
spleen, 
3. Localization  and Quantification  of the Sources of IL-3 Release.  The specific 20  GUT  MUCOSAL  MAST  CELLS 
release of IL-3  in  the  supernatants  of 48-h  culture  of lymphoid cells  in  the 
presence of crude Nb antigen was tested in three ways, as shown in Table II. 
The "MCGF" test measures the ability of IL-3 to sustain the cell division of a 
mast cell line established from BM, and the "HCSF" test, its ability to induce the 
synthesis and release of histamine by normal BM cells in short-term cultures (see 
Materials  and  Methods).  IL-3  release  induced  by  Nb  antigen  displayed  the 
expected specificity, since no release was observed using this antigen and cells of 
normal mice (Table  II),  and since a  different antigen, extracted from larvae 
instead of adult worms, was without effect (not shown). Specifically stimulated 
lymphoid cells from the gut mucosa, MLN,  and TD lymph, and to a  slightly 
lesser extent, spleen, release IL-3, between days 8 and 10 of infestation, while in 
contrast PLN or PP cells release very little or no IL-3 (Table II). IL-2 is released 
concomitantly with IL-3, and in order to compare the respective release of these 
lymphokines to that of similar sources from normal mice, MLN cells of normal 
and Nb-infested mice were stimulated by Con A. Table III shows that cells from 
infested mice released more IL-3 than IL-2, while cells from normal mice gave 
an opposite pattern.  The antigen-specific IL-3-releasing cells are Thy-1 + Lyt- 
1+2 - cells (Table II), apparently exclusively blasts as judged by cell fractionation 
at 1 g velocity sedimentation (not shown). Immediately after the worm rejection, 
on day 13, antigen-specific lymphokine release disappears, at least in the culture 
conditions used. 
4. Role of the Traffic of lL-3 Releasing T Blasts in Gut MMC Differentiation.  Since 
from day 8 to 10 postinfestation, the TD lymph contains many worm-specific T 
blasts able to secrete IL-3 (Table II). TD cannulation during this period should 
deplete the gut mucosa of the specific T  blasts that would have normally homed 
TABLE  II 
Lymphocyte Release of lL-3 Under the Influence of Nb Antigen in Mice 8-10 d after 
Infestation* 
Gut  MLN* 
Spleen  mu-  PP  Un-  Thy-  Lyt-  Lyt-  TDL  PLN 
cosa  treated  1-  2-  2 + 
(a)  "MCGF assay  "!  80  143  0  100  0  63  0  157  0 
(b)  "HCSF assay  "!  45  80  2.51  95  0  90  0  100  5 
(c)  Induction of MMC in cul-  +  +  0  +  0  +  0  +  0 
tures  of  normal  gut  mu- 
cosal cells** 
*  1 ×  108 cells stimulated by 48 h of culture with Nb antigen. Each value represents the average of 
2-8  experiments.  Cultures  were  performed  with  5%  human  AB  serum,  since  FCS  contains 
histaminase interfering with HCSF assay. 
* MLN cells were cultured untreated, after treatment with anti-Thy-1  +  C  (Thy-1-).  Lyt-2- and 
Lyt-2  + cells were obtained by panning of Lyt 2+-cells (after filtration of MLN cells on ny!on wool) 
0 Results are expressed as percentage of SH-TdR incorporation induced by an "optimal  amount 
of W3 sup on 3 d. bone marrow MMC cultures (average background around 200 cpm; average 
"100%" stimulation 25.000 cpm); final concentration of supernatants tested: 1/4. 
I Results expressed in HCSF units in the supernatant of 48 h BM cell culture (units refer to amount 
of histamine release (30). 
I This very low activity is observed even after enrichment in T  cells by passage through nylon wool. 
** See Materials and Methods. In order to allow gut MMC growth in these conditions, supernatants 
must contain an IL-3 concentration corresponding to at least 25 HCSF U/ml. GUY-GRAND  ET  AL.  21 
TABLE IlI 
Release of  lL-3 and IL-2 my MNL Cells from Normal and Nb-infected Mice, Stimulated by 
Con A or Nb Antigen* 
Supernatants of cultures performed in the presence of: 
IL-3*  IL-20 
--  AG  Con A  --  AG  Con A 
Normal MLN  0  0  10  0  0  50 
MLN from Nb mice (day 9)  0  180  260  1  35  25 
* Supernatants  obtained from 24-h cultures of l0 T  cells (after nylon wool filtration) in presence of 
Nb antigen or Con A (see Materials and Methods). 
* IL-3  was  tested  by the  ~MCGF assay" (supernatants  tested  at  dilutions  down  to  1/64  final 
concentration,  the value presented being the highest before decrease and was observed at 1116 
final concentration) and the results were expressed as in Table II (BKG 140 cpm, "100%": 6,000 
cpm). 
! IL-2 was tested with an IL-2-dependent cell line (supernatants tested at dilutions down to 1/64 
final concentration,  the value presented being the highest before decrease and was observed at 1/ 
16 final concentration)  and the results were expressed as percent of maximum SH-TdR incorpo- 
ration observed in the presence of a fraction  rich in rat IL-2 (BKG 400 cpm, "100%": 4 ×  104 
cpm). 
TABLE  IV 
Number of MMC Detectable on Tissue Sections in Nb-infested mice 
with or without 48 h Interruption of the T Cell Traffic* 
Infestation  Control mice  Cannulated  Mice with szp 
day  mice  on MLN 
0  0 
10  73  13 
13  136  48  54 
15  16  12 
* Gut sections were performed at 5 cm from the pylorus and MMC were 
numbered by 10 crypt villous units on tissue sections as described (2); 
results are the average of 2-4 experiments. 
there,  following the gut  T  cell cycle previously demonstrated  (16).  Indeed,  on 
day 10, gut mucosal cells of mice cannulated from day 8 released in the presence 
of the  worm antigen  ~10  times less IL-3 (average of 8  HCSF units)  than  cells 
from noncannulated  mice (average of 80  UCSF  units)  (Table  II). Although  it 
has been shown above that  TD  drainage on day 8  to  10 does not significantly 
decrease  gut  mucosa  MMC-P,  which  at  that  time  are  rapidly  dividing,  TD 
drainage  for  2  d  may modify  the  appearance  of histologically  detectable  gut 
MMC,  if their  full  differentiation  requires  constant  IL-3  release.  That  this  is 
indeed the case is shown on Table IV. TD cannulation  between day 11  and  13 
is less effective in decreasing gut MMC (Table IV), probably because the worm 
expulsion  is  well  advanced,  and  the  antigenic  stimulation  of T  cells  thus  de- 
creased. Selective S~p irradiation  of MLN for 2  d, which also interrupts  the gut 
T  cell traffic cycle, results in a  similar decrease in gut MMC (Table IV). At day 
15 the gut MMC increase has almost entirely waned, and prior TD cannulation 
is without,effect (Table IV), MMC-P frequency being also almost back to normal. 
This shows the short life of MMC (which are no longer dividing since day 13) in 
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Fetal gut grafts of mice grafted before Nb infestation were also examined. 
While the gut of the host contained histologically detectable MMC in markedly 
increased amounts,  no  MMC  could be detected in  the graft.  Since the grafts 
contained T  cells detectable by immunofluorescence, and  very probably  Nb- 
specific T  cells (16), this strongly suggests that worm antigen leads to local IL-3 
release, and was the missing element for MMC differentiation (no worms were 
found in the grafts of 10 infested animals). 
C.  MMC-P Traffic in the Rat 
As  mentioned above,  in  normal conditions gut mucosa MMC-P  are  mostly 
nondividing and are not released in the TD lymph. During Nb infestation, these 
cells start dividing and recirculating in the TD lymph: however, their traffic and 
homing, after in vitro SH-TdR labeling and injection in a  Nb-infested animal, 
cannot be adequately studied in the mouse, probably because of extensive cell 
division and difficulty in identifying early MMC on tissue sections. The situation 
is different in the rat: mature gut MMC are numerous even in normal conditions, 
and in newborn rats as well, and are located mostly within the LP where they 
are easily detectable. These cells are not dividing (few labeled cells 90 rain after 
in vivo 3H-TdR injection), but start rapid replication (40% of labeled cells after 
3H-TdR injection) on the 10th day of Nb-infestation (beginning of the self-cure). 
At  the  same  time,  dividing  immature  MMC,  with  small  granules  and  IgE 
receptors, are found among isolated intraepithelial lymphocytes ('globule leuco- 
cytes"; references 15, 35). At the end of the self-cure (16th to 18th day) there is 
about a  fourfold increase in gut MMC,  and division stops.  TD cells, obtained 
from normal and Nb-infested rats (10th day) were labeled in vitro and injected 
into Nb-infested rats (16th day). In both conditions, none of the TD blasts had 
granules.  1 and 2 d after transfer, autoradiographs of gut sections, stained both 
with  Alcian  blue  and  with  fluoresceinated  anti-IgA  serum,  were  prepared. 
Labeled MMC, clearly identifiable by Alcian blue (Fig. 3), represented a surpris- 
ingly high percentage of the labeled cells present in the gut mucosa, after transfer 
of TD blasts from both normal or Nb-infested donors, i.e., about one-third of 
the labeled cells that  were not  IgA plasma  cells (~10%  of total  labeled cells, 
average  of  five  experiments).  In  one  transfer  experiment,  TD  blasts  were 
separated by velocity sedimentation, and in a fraction of these blasts, OX 8 + cells 
FICURE 3.  Gut tissue section of 17-d Nb-infected rat, 24 h after transfer of SH-TdR-labeled 
thoracic duct blasts from normal rats. Two labeled alcian blue positive MMC are observed. GUY-GRAND  ET  AL.  23 
(equivalent of Lyt-2  + cells in mice) were removed by panning.  Labeled MMC 
were found in increased percentage in  the recipient of OX  8- blasts (48%  vs. 
25% of the IgA- labeled cells), which, in contrast, was nearly devoid of labeled 
IEL. This indicates that TD circulating MMC-P are OX 8- (as MMC-P are Lyt- 
2- in the mouse), and that the TD blasts that migrate to the gut epithelium are 
OX 8 +. 
When a fetal gut is grafted to normal and Nb-infested rats, MMC are present 
in the grafts of both types of recipients. Although the accuracy of cell counts is 
questionable, MMC were slightly increased in LP and no MMC were found in 
the epithelium  (contrary to  what  is  observed  in  the  recipient's  own  gut),  as 
reported by McDonald et al. (35). 
Discussion 
The discussion will be focused on two main points: the nature and properties 
of the gut MMC-P; the mechanisms leading to the production of large amounts 
of gut MMC during Nb rejection. 
Gut mucosal and BM cells are the populations where the MMC-P are by far 
the most frequent, in agreement with Crapper and Schrader (36). The following 
features of the gut MMC-P emerge from the present observations: (1)  Origin: 
gut  MMC-P  originate from the BM,  since there are no stem cells in  the gut 
mucosa, and since local splenic irradiation or splenectomy do not modify their 
amount. However, they differ somewhat from their BM progenitors (BM MMC- 
P):  (a) in contrast to BM MMC-P (reference 32 and present obervations), they 
do not divide unless stimulated, as shown by their lack of decrease after in vivo 
vinblastine  treatment,  (b)  in  culture,  BM  MMC-P  have  a  faster  growth  and 
transiently acquire Thy-1  antigen (reference 31  and present observations),  (c) 
gut MMC-P do not release histamine in the presence of IL-3,  while BM cells, 
probably BM MMC-P, do it on a large scale. All these features suggest that gut 
MMC-P represent a  more differentiated form of precursor than BM MMC-P, 
perhaps  as  the  result  of the  influence of a  "gut  factor" discussed below;  (2) 
surface  phenotype:  gut  MMC-P  bear  neither  Thy-1  nor  Lyt-2  antigens,  in 
agreement with Schrader et al. (37),  (3) traffic properties: (a) the striking gut- 
homing property of BM-derived circulating MMC-P is not related to any form 
of T  cell activity or antigenic stimulation, since the high frequency of gut MMC- 
P is observed in nude, germ-free, and newborn (i.e., before the gut seeding by 
IgA plasma cells and T  cells) mice, as well as in sterile grafts of fetal gut.  The 
attraction of MMC-P to the gut results from unknown factor(s), probably released 
in situ and perhaps responsible for the further differentiation of gut  MMC-P 
compared to BM MMC-P, as well as for the full MMC differentiation observed 
in  normal  rat  (see  below);  when  stimulated  by  IL-3,  gut  MMC-P  not  only 
proliferate, but also migrate in the efferent lymph, as witnessed by their enor- 
mous increase in frequency in  TDL.  Increased production and release by the 
BM probably require direct BM IL-3 stimulation, since a marked increase in BM 
MMC-P, associated with the emergence of BM  mast cells, is observed only in 
mice carrying the Wehi 3  tumor (which have detectable circulating IL-3), but 
not during  Nb  infestation,  when IL-3  release is  local,  (b)  at  least part  of the 
circulating TDL MMC-P remains endowed with gut-homing properties, so that 24  GUT  MUCOSAL  MAST  CELLS 
the whole length of the gut mucosa will  receive these cells, which, if the local 
stimulus to differentiation persists,  can rapidly be transformed into  MMC  (as 
shown  by  the  rat  TD  cell  transfer  experiments).  This  gut  cell  cycle closely 
resembles that followed by stimulated T  blasts and IgA-bearing blasts (although 
these arise, as previously shown, in the PP) (16), in allowing the dissemination to 
the whole mucosa (by unknown attractive factors) of the progeny of cells that 
were stimulated to divide locally in the gut. Even though activated, none of the 
cells undergoing this cycle and found in the TDL  have the features of early 
granulated mast cells; (4) fate of gut MMC-P: under the induction of local (Nb 
infection) or systemic (mice with Wehi 3 tumor) IL-3 release, proliferating MMC- 
P are transformed into characteristic early MMC (easily identifiable in gut mucosa 
cell suspension as blasts with few granules and little histamine, but bearing IgE 
receptors), then into fully differentiated MMC. In spite of the large increase in 
MMC  induced by  local  or  systemic IL-3  release,  it  seems likely that  not  all 
stimulated MMC-P are transformed in situ into MMC since, at least in the MLN 
and the spleen, the increase in MMC-P far exceeds that of MMC. The numerous 
MMC-P that do not reach the stage of differentiated MMC are clearly short- 
lived, since they disappear very quickly after the cessation of IL-3 stimulation, 
and this is also obviously true for mast cells, at least in the mice. 
The reason why some form of gut antigenic stimulation such as that repre- 
sented by Nb worms leads to a local immune response characterized, in contrast 
to most other responses, by a  massive accumulation of gut MMC,  reflects the 
capacity of these antigens to elicit an unusual T cell response. The T cell response 
observed in the gut during Nb infection appears similar to what we have described 
in other conditions with respect to origin, traffic cycle, and homing along the 
gut mucosa of TD circulating T  blasts, but different in one respect: the unusual 
extent of IL-3  release by  Lyt-l+2  -  T  blasts  upon  contact with  their  specific 
antigen. T  cells present in the gut as the result of usual antigenic stimulation, 
such as those observed in normal mice, release under Con A  stimulation more 
IL-2  than  IL-3,  while the converse is true in the case of Nb infestation. The 
mechanism of this  peculiar relationship  between the nature  of the antigenic 
stimulus and its effect on lymphokine release is not known. It may take place as 
soon as T  cells are stimulated in the PP. The lack of IL-3 release by PP cells 
stimulated in vitro by the Nb antigen probably indicates that T cells are immature 
and migrate as soon as specifically stimulated (the size and cell number of the PP 
is surprisingly decreased in Nb-infested mice). That IL-3 released by stimulated 
T  blasts present in the mucosa after their cycle through the TD is decisive in the 
appearance of gut MMC has been clearly shown by the effects of interruption of 
this cycle by 48-h TD cannulation or selective MLN irradiation. Such interrup- 
tion  leads  to  a  profound  decrease in  both  gut  T  blasts  releasing  IL-3  after 
exposure to Nb antigen and gut MMC (while MMC-P frequency in the gut is not 
modified). When massive antigenic stimulation abruptly stops, i.e., after worm 
rejection, IL-3  releasing specific T  blasts as well as gut MMC and circulating 
MMC-P all disappear very rapidly. 
The spleen is the only extra-intestinal location where increased numbers of 
Nb-specific T  blasts and MMC-P are found during Nb rejection. T  blasts may GUY-GRAND  ET  AL.  25 
reach the spleen through the TD and the blood, since transfer experiments of 
TD blasts have shown their homing in the spleen and not only in the gut; the 
increased frequency of MMC-P cannot, however, solely result from the same 
type of traffic,  since TD  drainage does  not  modify it  significantly.  It  seems 
therefore more likely that some antigen reaches the blood and the spleen, leading 
to some IL-3 release by specific T  blasts (as previously shown, reference 30) and 
thus  to  MMG-P  increase in  the  spleen;  although  local  IL-3  concentration  is 
obviously not sufficient to induce massive MMC transformation, some MMC are 
indeed observed in the spleen during Nb rejection. 
The situation of gut MMC in the rat appears somewhat different, and might 
shed some light on the various differentiation steps leading from BM MMC-P to 
fully differentiated gut  MMC.  Since  MMC  are always present  in  appreciable 
numbers in the gut LP of normal rats, the normal level of IL-3 might be higher 
in the rat, or the differentiation of LP MMC might be helped by an increased 
level  of factor(s) released by  the  gut  mucosa  itself,  such as  the  "gut  factor" 
postulated above to explain the attraction of BM-released, circulating MMC-P to 
the mouse gut in  the absence of IL-3  release (e.g. germ-free and nude mice). 
This last situation seems more likely since MMC appear in fetal gut grafts,  in 
normal rats (while there is no detectable MMC, but only MMC-P, in such grafts 
in mice, even during Nb infection). An increased level of this postulated "gut 
factor," enhancing the level of differentiation of MMC-P, might also explain a 
high frequency of MMC-P among the TD blasts of normal rats, as suggested by 
the results of the transfer experiments using TD blasts.  In this hypothesis, the 
transition of MMC-P to MMC would entail several steps (influenced by IL-3 and 
a "gut factor") which may be schematized as follows: (a) BM MMC-P, released in 
the circulation; (b) gut MMC-P, sessile;  (c) activated gut MMC-P, dividing and 
circulating; (d) early gut MMC, dividing; (e) fully mature gut MMC, short-lived. 
Finally, the relationship between gut MMC and the gut intraepithelial lympho- 
cytes with small mast-cell-like granules should be discussed. We had previously 
speculated  that  the  latter  could  be  an  "aborted"  variant  of the  former,  in 
conditions where the stimulation for full MMC differentiation was insufficient. 
We had noticed that the most granulated of these IE lymphocytes had weak or 
no Thy-1 antigen, and found subsequently that most of these cells are Lyt-2  +, 
and OX 8 + in the rat and, as detected by double immunofluorescence, mostly 
Thy-l-,  Lyt-2  + (38,  40),  in  agreement with  the recent observations  of other 
workers (37,  39).  It is clear for the present and Schrader's et al.  experiments 
that these cells do not behave as MMC-P. While we found that these cells undergo 
modifications (increase in proliferation rate and gTanule size) during Nb rejec- 
tion, we never observed evidence for a transition towards MMC, for instance the 
simultaneous presence of Lyt-2 antigens and IgE receptors. It is apparent that 
these cells, like most gut T  cells, are the progeny of TD blasts (they decrease 
concomitantly with  gut  T  cells  when  the  cycle is  interrupted  by  S2p  MLN 
irradiation in contrast with the absence of effect of S~p spleen irradiation) and 
that  they acquire  their  characteristics  under a  local  gut  influence,  which  is 
increased during NB rejection. Their nature is the subject of further study. 26  GUT  MUCOSAL MAST CELLS 
Summary 
Gut mucosal mast cells (MMC), which are nearly absent in normal  mice are 
abundant during nematode infection. In normal mice, study of MMC precursors 
(MMC-P: cells giving rise to MMC colonies in the presence of IL-3) show that: 
(a) their frequency,judged by limiting dilution is very high in bone marrow (BM) 
and gut, and very low in most lymphoid organs and thoracic duct lymph (TDL); 
(b) gut MMC-P are Thy-1- Lyt-l-2- and are not rapidly replicating; (c) they are 
the  progeny  of less differenciated  BM  MMC-P  which  are  attracted  from  the 
blood to the gut mucosa by local factor(s), other than antigen and T  cell factors 
(since normal amounts of gut MMC-P are found in germ-free, nude, and newborn 
mice). In mice bearing the Wehi 3 tumor (which releases enough IL-3 to produce 
detectable blood levels) spleen and mesenteric lymph nodes (LN) show increased 
MMC-P  frequency,  the  greatest  increase  being  in  the  gut  and  BM,  where 
numerous  differentiated  MMC are  found.  In  Nippostrongylus  brasiliensis  (Nb)- 
infested mice (known to develop a  large, T  cell-dependent,  gut MMC infiltra- 
tion),  gut MMC-P proliferation  is induced  by IL-3  released from gut  mucosal 
Thy-1 + Lyt-2- cells, whose in vitro IL-3 release capability is much higher than 
that of similar cells from normal mice.  Both Nb-stimulated T  blasts and prolif- 
erating MMC-P undergo cyclic traffic, migrating into the TDL and then seeding 
the whole length of the gut (a process which allows a widespread immune defense 
after a local antigenic stimulus). Experiments using 2-d interruption of this traffic 
and fetal gut grafts, suggest that the continuous homing of T  blasts back to the 
gut which leads to permanent Nb-stimulated IL-3 release, is essential for the full 
maturation of MMC. Transfer experiments in the rat show that TDL circulating 
MMC-P rapidly mature into MMC when they home back to the Nb-infested gut. 
It is proposed that gut MMC arise after several stages of progressive differentia- 
tion of MMC-P, influenced both by IL-3 and unidentified gut factor(s). 
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